Since its discovery at the end of the nineteenth century, Moraxella (Branhamella) catarrhalis has undergone several changes of nomenclature and periodic changes in its perceived status as either a commensal or a pathogen. Molecular analysis based on DNA hybridisation or 16S rDNA sequence comparisons has established its phylogenetic position as a member of the Moraxellaceae and shown that it is related more closely to Acinetobacter spp. than to the genus Neisseria in which it was placed formerly. However, confusion with phenotypically similar Neisseria spp. can occur in the routine diagnostic laboratory if appropriate identification tests are not performed. M. catarrhalis is now accepted as the third commonest pathogen of the respiratory tract after Streptococcus pneumoniae and Haemophilus influenzae. It is a significant cause of otitis media and sinusitis in children and of lower respiratory tract infections in adults, especially those with underlying chest disease. Nosocomial spread of infection, especially within respiratory wards, has been reported. Invasive infection is uncommon, but analysis of reports for England and Wales between 1992 and 1995 revealed 89 cases of M. catarrhalis bacteraemia, with the peak incidence in children aged 1-2 years. Carriage rates of M. catarrhalis are high in children and in the elderly, but its role as a commensal organism has probably been overstated in the past. Approximately 90% of strains are now β-lactamase positive and, given that the first such strain was reported in 1976, this represents a dramatic increase in frequency over the last 20 years which has not been paralleled in any other species. The BRO-1 and BRO-2 β-lactamase enzymes of M. catarrhalis are found in other Moraxellaceae, but are not related to β-lactamases of any other species and their origin is therefore unknown. Molecular and typing studies have shown that the M. catarrhalis species is genetically heterogeneous and these methods have aided epidemiological investigation. Studies of factors that may be related to pathogenicity have shown the existence of three serotypes of lipooligosaccharide and the presence of fimbriae and a possible capsule. Some strains are serum-resistant, probably by virtue of interference with complement action, whilst transferrin- and lactoferrin-binding proteins enable the organism to obtain iron from its environment. An antibody response in humans to various M. catarrhalis antigens, including highly conserved outer-membrane proteins, has been demonstrated. Increased understanding of the organism’s pathogenic properties and the host response to it may help to identify suitable vaccine targets or lead to other strategies to prevent infection. Whilst it remains, at present, the third most important respiratory pathogen, the impact of immunisation strategies for other organisms may change this position. The speed with which M. catarrhalis acquired β-lactamase demonstrates the capacity of this organism to surprise us.
BovreK. The genus Moraxella. In
KriegN. R.,
HoltJ. G.
(eds) Bergey’s Manual of systematic bacteriology vol 1 Baltimore, USA: Williams and Wilkins; 1984296–303
VeronM.,
Lenvoise-FuretA.,
CoustereC.,
GedC.,
GrimontF. Relatedness of three species of “false Neisseria”, Neisseria caviae, Neisseria cuniculi, and Neisseria ovis, by DNA-DNA hybridizations and fatty-acid analysis. Int J Syst Bacteriol1993; 43:210–220
RossauR.,
Van LandschootA.,
GillisM.,
de LeyJ. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accommodate the genera Moraxella, Acinetobacter, and Psychrobacter and related organisms. Int J Syst Bacteriol1991; 41:310–319
EnrightM. C.,
CarterP. E.,
MacLeanI. A.,
McKenzieH. Phylogenetic relationships between some members of the genera Neisseria, Acinetobacter, Moraxella, and Kingella based on partial 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol1994; 44:387–391
AhmadF.,
YoungH.,
McLeodD. T.,
CroughanM. J.,
CalderM. A. Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory. J Clin Pathol1987; 40:1369–1373
PeirisV.,
RalphsonK.,
NorrisS.,
BennettC. Not Branhamella catarrhalis: misidentification of oxidase-positive, Gram-negative cocci isolated from the genital tract. J Infect1993; 27:338–339
FadenH.,
HarabuchiY.,
HongJ. J. and Tonawanda/Williamsville Pediatrics. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis1994; 169:1312–1317
EjlertsenT.,
ThistedE.,
EbbesenF.,
OlesenB.,
RennebergJ.Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect1994; 29:23–31
VaneechoutteM.,
VerschraegenG.,
ClaeysG.,
WeiseB.,
van den AbeeleA. M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol1990; 28:2674–2680
DickinsonD. P.,
LoosB. G.,
DryjaD. M.,
BernsteinJ. M. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis1988; 158:205–208
Jousimies-SomerH. R.,
SavolainenS.,
YlikoskiJ. S. Bacteriological findings of acute maxillary sinusitis in young adults. J Clin Microbiol1988; 26:1919–1925
SlevinN. J.,
AitkenJ.,
ThomleyP. E. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet1984; 1:782–783
ThomleyP. E.,
AitkenJ.,
DrennanC. J.,
Mac VicarJ.,
SlevinN. J.Branhamella catarrhalis infection of the lower respiratory tract: reliable diagnosis by sputum examination. BMJ1982; 285:1537–1538
YuenK. Y.,
SetoW. H.,
OngS. G. The significance of Branhamella catarrhalis in bronchopulmonary infection - a case- control study. J Infect1989; 19:251–256
DiGiovanniC.,
RileyT. V.,
HoyneG. F.,
YeoR.,
CookseyP. Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiol Infect1987; 99:445–453
McLeodD. T.,
AhmadF.,
CapewellS.,
CroughanM. J.,
CalderM. A.,
SeatonA. Increase in bronchopulmonary infection due to Branhamella catarrhalis. BMJ1986; 292:1103–1105
AlligoodG. A.,
KennyJ. F. Tracheitis and supraglottis associated with Branhamella catarrhalis and respiratory syncytial vims. Pediatr Infect Dis J1989; 8:190–191
MeyerG. A.,
ShopeT. R.,
WaeckerN. J.,
LanninghamF. H.Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clin Pediatr1995; 34:146–150
CollazosJ.,
de MiguelJ.,
AyarzaR.Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin Microbiol Infect Dis1992; 11:237–240
PattersonT. F.,
PattersonJ. E.,
MasecarB. L.,
BardenG. E.,
HierhalzerW. J.,
ZervosM. J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis1988; 157:996–1001
McKenzieH.,
MorganM. G.,
JordensJ. Z.,
EnrightM. C.,
BainM. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol1992; 37:70–76
MorganM. G.,
McKenzieH.,
EnrightM. C.,
BainM.,
EmmanuelF. X. S. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis1992; 11:305–312
IkramR. B.,
NixonM.,
AitkenJ.,
WellsE. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J Hosp Infect1993; 25:7–14
WallaceR. J.,
SteingrubeV. A.,
NashD. R. BRO f- lactamases of Branhamella catarrhalis, and Moraxella subgenus Moraxella, including evidence for chromosomal f- lactamase transfer by conjugation in B. catarrhalis M. nonliquefaciens, and M. lacunata. Antimicrob Agents Che-mother1989; 33:1845–1854
WallaceR. J.,
NashD. R.,
SteingrubeV. A. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am J Med1990; 88: Suppl 5A46S–50S
FungC. P.,
PowellM.,
SeymourA.,
YuanM.,
WilliamsJ. D. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. J Antimicrob Chemother1992; 30:47–55
NashD. R.,
WallaceR. J.,
SteingrubeV. A.,
ShurinP. A. Isoelectric focusing of /3-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs1986; 31: Suppl 348–54
SteingrubeV. A.,
WallaceR. J.,
BeaulieuD. A membrane-bound precursor /3-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 /3-lactamases. J Antimicrob Chemother1993; 31:237–244
MolstadS.,
EliassonI.,
HoveliusB.,
KammeC.,
SchalenC. Beta-lactamase production in the upper respiratory tract flora in relation to antibiotic consumption: a study in children attending day nurseries. Scand J Infect Dis1988; 20:329–334
HoiC.,
van DijkeE. E. M.,
VerduinC. M.,
VerhoefJ.,
van DijkH. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis1994; 170:1613–1616
RobertsM. C.,
PangY.,
SpencerR. C.,
WinstanleyT. G.,
BrownB. A.,
WallaceR. J. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob Agents Chemother1991; 35:2453–2455
VaneechoutteM.,
VerschraegenG.,
ClaeysG.,
van den AbeeleA.-M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol1990; 28:182–187
FoxR. H.,
McClainD. E. Evaluation of the taxonomic relationship of Micrococcus cryophilus, Branhamella catarrhalis, and Neisseriae by comparative polyacrylamide gel electrophoresis of soluble proteins. Int J Syst Bacteriol1974; 24:172–176
CookP. P.,
HechtD. W.,
SnydmanD. R. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect1989; 13:299–307
KawakamiY.,
UenoI.,
KatsuyamaT.,
FurihataK.,
MatsumotoH. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol1994; 38:891–895
TenoverF. C.,
ArbeitR. D.,
GoeringR. V. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol1995; 33:2233–2239
SelanderR. K.,
CaugantD. A.,
WhittamT. S. Genetic structure and variation in natural populations of Escherichia coli. In
NeidhardtF. C.,
IngrahamJ. L.,
LawK. B.,
MagasanikB.,
SchaechterM.,
UmbargerH. E.
(eds) Escherichia coli and Salmonella typhimurium: cellular and molecular biology vol 2 Washington, USA: American Society for Microbiology; 19871625–1648
MurphyT. F. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J1989; 81: Suppl S75–S77
EdebrinkP.,
JanssonP.-E.,
RahmanM. M. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res1994; 257:269–284
MasoudH.,
PerryM. B.,
BrissonJ.-R.,
UhrinD.,
RichardsJ. C. Structural elucidation of the backbone oligosaccharide from the lipopolysaccharide of Moraxella catarrhalis serotype A. Can J Chem1994; 72:1466–1477
RahmanM.,
HolmeT. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J Med Microbiol1996; 44:348–354
EdebrinkP.,
JanssonP.-E.,
RahmanM. M.,
WidmalmG.,
HolmeT.,
RahmanM. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr Res1995; 266:237–261
BeacheyE. H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis1981; 143:325–345
HermodsonM. A.,
ChenK. C. S.,
BuchananT. M. Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid. Biochemistry1978; 17:442–445
SastryP. A.,
PearlstoneJ. R.,
SmillieL. B.,
ParanchychW. Amino acid sequence of pilin isolated from Pseudomonas aeruginosa PAK. FEBS Lett1983; 151:253–256
TaylorR. K.,
MillerV. L.,
FurlongD. B.,
MekalanosJ. J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA1987; 84:2833–2837
MarrsC. F.,
SchoolnikG.,
KoomeyJ. M.,
HardyJ.,
RothbardJ.,
FalkowS. Cloning and sequencing of a Moraxella bovis pilin gene. J Bacteriol1985; 163:132–139
RuehlW. W.,
MarrsC. F.,
FernandezR.,
FalkowS.,
SchoolnikG. K. Purification, characterization, and pathogenicity of Moraxella bovis pili. J Exp Med1988; 168:983–1002
AhmedK.,
MasakiH.,
DaiT. C. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections. Microbiol Immunol1994; 38:767–771
AhmedK.,
MatsumotoK.,
RikitomiN.,
NagatakeT. Attachment of Moraxella catarrhalis to pharyngeal epithelial cells is mediated by a glycosphingolipid receptor. FEMS Microbiol Lett1996; 135:305–309
VerduinC. M.,
JanszeM.,
HoiC.,
MollnesT. E.,
VerhoefJ.,
van DijkH. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun1994; 62:589–595
HelminenM. E.,
MaciverI.,
ParisM. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis1993; 168:1194–1201
HoiC.,
VerduinC. M.,
Van DykeE. E. A.,
VerhoefJ.,
FleerA.,
van DijkH. Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. FEMS Immunol Med Microbiol1995; 11:207–212
SchryversA. B.,
LeeB. C. Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae. Can J Microbiol1989; 35:409–415
CampagnariA. A.,
ShanksK. L.,
DyerD. W. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect Immun1994; 62:4909–4914
NovotnyP.,
ShortJ. A.,
WalkerP. D. An electron-microscope study of naturally occurring and cultured cells of Neisseria gonorrhoeae. J Med Microbiol1975; 8:413–427
ReynA. Family I. Neisseriaceae Prevot. In
BuchananR. E.,
GibbonsN. E.
(eds) Bergey’s Manual of determinative bacteriology 8th edn Baltimore: Williams and Wilkins; 1974427-433–442-443
HellioR.,
GuibourdencheM.,
CollatzE.,
RiouJ. Y. The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy. Ann Inst Pasteur Microbiol1988; 139:515–525
DevaliaJ. L.,
GradyD.,
HarmanyeriY.,
TabaqchaliS.,
DaviesR. J. Histamine synthesis by respiratory tract micro-organisms: possible role in pathogenicity. J Clin Pathol1989; 42:516–522
GoldblattD.,
TurnerM. W.,
LevinskyR. J.Branhamella catarrhalis. antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis1990; 162:1128–1135
CarsonR. T.,
McDonaldD. F.,
KehoeM. A.,
CalvertJ. E. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis. Immunology1994; 83:107–113
HelminenM. E.,
MaciverI.,
LatimerJ. L. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis1994; 170:867–872
HelminenM. E.,
BeachR.,
MaciverI.,
JarosikG.,
HansenE. J.,
LeinonenM. Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin Diagn Lab Immunol1995; 2:35–39
SethiS.,
HillS. L.,
MurphyT. F. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun1995; 63:1516–1520
SarwarJ.,
CampagnariA. A.,
KirkhamC.,
MurphyT. F. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect Immun1992; 60:804–809